JavaScript is disabled for your browser. Some features of this site may not work without it.
Get the latest COVID-19 technical guidance, scientific and policy briefs here.✕
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

PAHO IRIS

Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran

Thumbnail
View/Open
12_5_2006_528_537.pdf (‎444.3Kb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
  • CSV
  • Excel
  • BibTeX
  • RIS
Abstract
We determined the seroprevalence of hepatitis B in Nahavand in a sample of 1824 subjects > 5 years in 2002. Face- to- face interviews were conducted and blood samples taken. The association between risk factor and hepatitis B was assessed using logistic regression. The prevalence of HbsAg positive cases was 2.3%, and HBcAb and HBsAb were isolated in 7.8% and 11.6% of the participants respectively; 11.9% were positive for both HBcAb and HBsAb. History of surgery and imprisonment were the major risk factors for infection with odds ratios of 2.14 [‎95% CI: 1.22- 3.05]‎ and 3.57 [‎95% CI: 1.68- 5.4]‎ respectively
Citation
Alizadeh, A.H.M., Ranjbar, M., Ansari, S., MirArab, A., Alavian, S.M. et al. (‎2006)‎. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. EMHJ - Eastern Mediterranean Health Journal, 12 (‎5)‎, 528-537, 2006 https://apps.who.int/iris/handle/10665/117114
Journal
EMHJ - Eastern Mediterranean Health Journal, 12 (‎5)‎, 528-537, 2006
Description
528-537
ISSN
1020-3397
Other Identifiers
http://applications.emro.who.int/emhj/1205/12_5_2006_528_537.pdf
Language
English
Collections
  • EMRO Journal Articles (‎EMHJ)‎
Metadata
Show full item record

Show Statistical Information

View Item 
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item

© 2021 WHO